Latest Insider Transactions at Life Stance Health Group, Inc. (LFST)
This section provides a real-time view of insider transactions for Life Stance Health Group, Inc. (LFST). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of LifeStance Health Group, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of LifeStance Health Group, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 13
2024
|
Paula Cipollone |
SELL
Open market or private sale
|
Direct |
48,278
-16.75%
|
$337,946
$7.22 P/Share
|
|
May 10
2024
|
Paula Cipollone |
SELL
Open market or private sale
|
Direct |
2,000
-0.69%
|
$14,000
$7.0 P/Share
|
|
Apr 01
2024
|
Danish J. Qureshi |
SELL
Open market or private sale
|
Direct |
12,965
-0.26%
|
$64,825
$5.93 P/Share
|
|
Apr 01
2024
|
Kevin Michael Mullins Chief Development Officer |
SELL
Open market or private sale
|
Direct |
9,688
-0.2%
|
$48,440
$5.93 P/Share
|
|
Apr 01
2024
|
Pablo Pantaleoni Chief Digital Officer |
SELL
Open market or private sale
|
Direct |
10,116
-0.77%
|
$50,580
$5.93 P/Share
|
|
Apr 01
2024
|
Ryan Pardo |
SELL
Open market or private sale
|
Direct |
9,830
-1.2%
|
$49,150
$5.93 P/Share
|
|
Mar 15
2024
|
Kenneth A Burdick |
SELL
Open market or private sale
|
Direct |
214,605
-6.82%
|
$1,287,630
$6.28 P/Share
|
|
Mar 14
2024
|
Kevin Michael Mullins Chief Development Officer |
SELL
Open market or private sale
|
Direct |
44,540
-0.93%
|
$267,240
$6.33 P/Share
|
|
Mar 14
2024
|
Ryan Pardo |
SELL
Open market or private sale
|
Direct |
39,384
-4.59%
|
$236,304
$6.33 P/Share
|
|
Mar 13
2024
|
Danish J. Qureshi |
SELL
Open market or private sale
|
Direct |
153,943
-3.03%
|
$923,658
$6.32 P/Share
|
|
Mar 12
2024
|
Pablo Pantaleoni Chief Digital Officer |
SELL
Open market or private sale
|
Direct |
43,304
-3.2%
|
$259,824
$6.76 P/Share
|
|
Mar 11
2024
|
Paula Cipollone |
SELL
Open market or private sale
|
Direct |
13,996
-4.55%
|
$83,976
$6.93 P/Share
|
|
Mar 11
2024
|
Ann Varanakis Chief People Officer |
SELL
Open market or private sale
|
Direct |
15,434
-5.44%
|
$92,604
$6.93 P/Share
|
|
Mar 11
2024
|
David Bourdon Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
58,826
-11.94%
|
$352,956
$6.93 P/Share
|
|
Mar 08
2024
|
Paula Cipollone |
BUY
Grant, award, or other acquisition
|
Direct |
94,465
+13.95%
|
-
|
|
Mar 08
2024
|
Ryan Pardo |
BUY
Grant, award, or other acquisition
|
Direct |
220,700
+12.07%
|
-
|
|
Mar 08
2024
|
Kevin Michael Mullins Chief Development Officer |
BUY
Grant, award, or other acquisition
|
Direct |
214,412
+2.21%
|
-
|
|
Mar 08
2024
|
Ujjwal Ramtekkar Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
62,413
+50.0%
|
-
|
|
Mar 08
2024
|
Danish J. Qureshi |
BUY
Grant, award, or other acquisition
|
Direct |
494,554
+4.75%
|
-
|
|
Mar 08
2024
|
Pablo Pantaleoni Chief Digital Officer |
BUY
Grant, award, or other acquisition
|
Direct |
226,873
+8.03%
|
-
|
|
Mar 08
2024
|
Kenneth A Burdick |
BUY
Grant, award, or other acquisition
|
Direct |
787,867
+11.82%
|
-
|
|
Mar 08
2024
|
Ann Varanakis Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
115,269
+17.5%
|
-
|
|
Mar 08
2024
|
David Bourdon Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
228,666
+21.11%
|
-
|
|
Mar 01
2024
|
Kevin Michael Mullins Chief Development Officer |
SELL
Open market or private sale
|
Direct |
115,136
-2.45%
|
$921,088
$8.02 P/Share
|
|
Jan 03
2024
|
Paula Cipollone |
SELL
Open market or private sale
|
Direct |
3,369
-1.15%
|
$23,583
$7.45 P/Share
|
|
Dec 01
2023
|
Kevin Michael Mullins Chief Development Officer |
SELL
Open market or private sale
|
Direct |
113,334
-2.36%
|
$680,004
$6.54 P/Share
|
|
Nov 07
2023
|
Kevin Michael Mullins Chief Development Officer |
SELL
Open market or private sale
|
Direct |
32,056
-0.66%
|
$192,336
$6.12 P/Share
|
|
Nov 06
2023
|
Kevin Michael Mullins Chief Development Officer |
SELL
Open market or private sale
|
Direct |
300
-0.01%
|
$1,800
$6.12 P/Share
|
|
Nov 03
2023
|
Kevin Michael Mullins Chief Development Officer |
SELL
Open market or private sale
|
Direct |
80,977
-1.65%
|
$485,862
$6.13 P/Share
|
|
Oct 02
2023
|
Kevin Michael Mullins Chief Development Officer |
SELL
Open market or private sale
|
Direct |
113,333
-2.25%
|
$679,998
$6.61 P/Share
|
|
Sep 01
2023
|
Warren Gouk Chief Administrative Officer |
SELL
Open market or private sale
|
Direct |
38,058
-0.65%
|
$304,464
$8.25 P/Share
|
|
Aug 31
2023
|
Warren Gouk Chief Administrative Officer |
SELL
Open market or private sale
|
Direct |
11,966
-0.2%
|
$95,728
$8.25 P/Share
|
|
Aug 24
2023
|
Ann Varanakis Chief People Officer |
SELL
Open market or private sale
|
Direct |
5,661
-3.25%
|
$39,627
$7.6 P/Share
|
|
Jul 06
2023
|
Kevin Michael Mullins Chief Development Officer |
SELL
Open market or private sale
|
Direct |
135,400
-2.62%
|
$1,083,200
$8.67 P/Share
|
|
Jul 05
2023
|
Kevin Michael Mullins Chief Development Officer |
SELL
Open market or private sale
|
Direct |
150,000
-2.82%
|
$1,200,000
$8.72 P/Share
|
|
Jul 03
2023
|
Kevin Michael Mullins Chief Development Officer |
SELL
Open market or private sale
|
Direct |
54,600
-1.02%
|
$491,400
$9.0 P/Share
|
|
Jul 01
2023
|
Robert Bessler |
BUY
Grant, award, or other acquisition
|
Direct |
21,905
+50.0%
|
-
|
|
Jul 01
2023
|
Eric Shuey |
BUY
Grant, award, or other acquisition
|
Direct |
21,905
+50.0%
|
-
|
|
Jul 01
2023
|
William Joseph Miller |
BUY
Grant, award, or other acquisition
|
Direct |
21,905
+4.92%
|
-
|
|
Jul 01
2023
|
Seema Verma |
BUY
Grant, award, or other acquisition
|
Direct |
21,905
+17.76%
|
-
|
|
Jun 28
2023
|
Anisha Patel Dunn Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,602
-0.93%
|
$23,418
$9.24 P/Share
|
|
Jun 26
2023
|
Ryan Pardo |
SELL
Open market or private sale
|
Direct |
50,136
-7.3%
|
$401,088
$8.91 P/Share
|
|
Jun 23
2023
|
Kevin Michael Mullins Chief Development Officer |
SELL
Open market or private sale
|
Direct |
65,832
-1.21%
|
$592,488
$9.02 P/Share
|
|
Jun 22
2023
|
Warren Gouk Chief Administrative Officer |
SELL
Open market or private sale
|
Direct |
57,754
-0.97%
|
$519,786
$9.05 P/Share
|
|
Jun 21
2023
|
Danish J. Qureshi |
SELL
Open market or private sale
|
Direct |
72,398
-0.78%
|
$651,582
$9.05 P/Share
|
|
Jun 14
2023
|
Warren Gouk Chief Administrative Officer |
SELL
Open market or private sale
|
Direct |
45,984
-0.77%
|
$367,872
$8.95 P/Share
|
|
Jun 13
2023
|
Warren Gouk Chief Administrative Officer |
SELL
Open market or private sale
|
Direct |
47,142
-0.78%
|
$377,136
$8.71 P/Share
|
|
Jun 12
2023
|
Warren Gouk Chief Administrative Officer |
SELL
Open market or private sale
|
Direct |
2,858
-0.05%
|
$22,864
$8.51 P/Share
|
|
Apr 04
2023
|
Kevin Michael Mullins Chief Development Officer |
SELL
Open market or private sale
|
Direct |
76,133
-0.69%
|
$532,931
$7.62 P/Share
|
|
Apr 04
2023
|
Anisha Patel Dunn Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
7,319
-2.55%
|
$51,233
$7.62 P/Share
|